Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVGR Avinger	$0.47	$0.47	$0.36 ▼ $1.93	$1.57M	1.29	1.34 million shs	N/A
CUTR Cutera	$0.04 -63.9%	$0.04	$0.09 ▼ $1.87	$787K	1.36	2.78 million shs	27.70 million shs
NUWE Nuwellis	$0.20 -10.7%	$0.65	$0.19 ▼ $5.84	$860K	0.28	3.46 million shs	2.25 million shs
SONX Sonendo	$1.15	$1.24	$1.00 ▼ $17.00	$493K	1.5	1,012 shs	N/A

The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVGR Avinger	0.00%	0.00%	0.00%	0.00%	-73.07%
CUTR Cutera	0.00%	0.00%	0.00%	0.00%	-96.98%
NUWE Nuwellis	-10.71%	-24.03%	-74.58%	-76.39%	-95.24%
SONX Sonendo	0.00%	0.00%	-12.21%	-8.00%	+1,540.51%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AVGR Avinger	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CUTR Cutera	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	1.8428 of 5 stars	3.5	2.0	0.0	0.0	0.6	0.0	1.3
SONX Sonendo	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVGR Avinger	0.00	N/A	N/A	N/A
CUTR Cutera	2.50	Moderate Buy	$3.00	7,592.31% Upside
NUWE Nuwellis	3.00	Buy	$17.00	8,573.47% Upside
SONX Sonendo	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest SONX, AVGR, NUWE, and CUTR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
5/13/2025	NUWE Nuwellis	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy

(Data available from 7/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVGR Avinger	$7.65M	0.21	N/A	N/A	($4.53) per share	-0.10
CUTR Cutera	$155.21M	0.01	N/A	N/A	($8.62) per share	0.00
NUWE Nuwellis	$8.74M	0.10	N/A	N/A	$1.49 per share	0.13
SONX Sonendo	$44.40M	0.01	N/A	N/A	$89.42 per share	0.01

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVGR Avinger	-$18.32M	-$11.06	N/A	N/A	N/A	N/A	N/A	N/A	8/6/2025 (Estimated)
CUTR Cutera	-$162.83M	-$6.58	N/A	N/A	N/A	-84.86%	N/A	-45.07%	8/6/2025 (Estimated)
NUWE Nuwellis	-$11.16M	-$18.24	N/A	N/A	N/A	-112.09%	-655.31%	-141.83%	8/12/2025 (Estimated)
SONX Sonendo	-$60.92M	-$59.12	N/A	∞	N/A	-92.74%	-184.01%	-68.60%	8/8/2025 (Estimated)

Latest SONX, AVGR, NUWE, and CUTR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
5/13/2025	Q1 2025	NUWE Nuwellis	-$0.45	-$0.69	-$0.24	-$0.69	$2.50 million	$1.90 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVGR Avinger	N/A	N/A	N/A	N/A	N/A
CUTR Cutera	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	N/A	N/A	N/A	N/A	N/A
SONX Sonendo	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVGR Avinger	N/A	N/A	N/A
CUTR Cutera	N/A	2.88	1.86
NUWE Nuwellis	N/A	2.23	1.59
SONX Sonendo	0.55	1.82	1.22

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVGR Avinger	18.30%
CUTR Cutera	90.70%
NUWE Nuwellis	3.13%
SONX Sonendo	28.68%

Insider Ownership

Company	Insider Ownership
AVGR Avinger	42.80%
CUTR Cutera	0.42%
NUWE Nuwellis	1.60%
SONX Sonendo	7.90%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVGR Avinger	70	3.31 million	1.89 million	Not Optionable
CUTR Cutera	460	20.19 million	20.10 million	Optionable
NUWE Nuwellis	70	4.37 million	4.30 million	Not Optionable
SONX Sonendo	250	429,000	393,000	Not Optionable

SONX, AVGR, NUWE, and CUTR Headlines

Recent News About These Companies

Sonendo, Inc. Reports First Quarter 2025 Financial Results and Issues Financial Guidance

June 4, 2025 | businesswire.com

Sonendo Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

March 26, 2025 | businesswire.com

Sonendo, Inc. to Release Third Quarter 2024 Financial Results and Postpone Conference Call on November 12, 2024

November 11, 2024 | businesswire.com

Sonendo, Inc. (SONX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

November 5, 2024 | zacks.com

Sonendo Launches ProControlTM for the GentleWave® G4 System

October 23, 2024 | businesswire.com

Sonendo, Inc. Announces Preliminary Third Quarter 2024 Financial Results

October 10, 2024 | businesswire.com

BIOLASE files for Chapter 11, plans asset sale to Sonendo

October 3, 2024 | investing.com

Here's Why Sonendo (SONX) Is a Great 'Buy the Bottom' Stock Now

August 27, 2024 | zacks.com

Sonendo Inc.

August 17, 2024 | marketwatch.com

Sonendo, Inc. (SONX) Q2 2024 Earnings Call Transcript

August 10, 2024 | seekingalpha.com

Sonendo, Inc. (SONX) Reports Q2 Loss, Tops Revenue Estimates

August 7, 2024 | zacks.com

Sonendo, Inc. Reports Second Quarter 2024 Financial Results and Raises Full Year Revenue Guidance

August 7, 2024 | finance.yahoo.com

Here's what Wall Street expects from Sonendo's earnings report

August 7, 2024 | markets.businessinsider.com

Sonendo, Inc. (SONX)

July 28, 2024 | finance.yahoo.com

Sonendo Strengthens Leadership With Key Strategic Appointments

June 5, 2024 | businesswire.com

Sonendo to Present at the 2024 Stifel Jaws & Paws Conference

May 20, 2024 | businesswire.com

Sonendo, Inc. (SONX) Q1 2024 Earnings Call Transcript

May 12, 2024 | seekingalpha.com

Sonendo, Inc. (NYSE:SONX) Q1 2024 Earnings Call Transcript

May 12, 2024 | msn.com

Sonendo Inc (SONX) Q1 2024 Earnings Call Transcript Highlights: Strategic Shifts and Financial ...

May 9, 2024 | finance.yahoo.com

SONX Stock Earnings: Sonendo Misses EPS, Beats Revenue for Q1 2024

May 8, 2024 | investorplace.com

Media Sentiment Over Time

SONX, AVGR, NUWE, and CUTR Company Descriptions

Avinger NASDAQ:AVGR

$0.47 0.00 (0.00%)

As of 07/1/2025

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. Its lumivascular products comprise Lightbox imaging consoles; the Ocelot and Tigereye family of devices, which are designed to allow physicians to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. The company is also developing IMAGE-BTK for the treatment of PAD lesions below-the-knee. It markets and sells its products to interventional cardiologists, vascular surgeons, and interventional radiologists. The company was incorporated in 2007 and is based in Redwood City, California.

Cutera NASDAQ:CUTR

$0.04 -0.07 (-63.86%)

Closing price 03/12/2025

Extended Trading

$0.04 0.00 (0.00%)

As of 03/12/2025 07:59 PM Eastern

Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and Enlighten SR/III, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides Excel HR, a hair removal solution for all skin types; xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; and Secret DUO, two dual non-ablative fractional technologies that can be used individually or in combination to target a variety of aesthetic concerns and skin conditions on all skin types with little to no downtime. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.

Nuwellis NASDAQ:NUWE

$0.20 -0.02 (-10.71%)

Closing price 07/3/2025 03:58 PM Eastern

Extended Trading

$0.20 +0.00 (+0.51%)

As of 07/3/2025 04:49 PM Eastern

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Sonendo NYSE:SONX

$1.15 0.00 (0.00%)

As of 07/3/2025

Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada. It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system. In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners. The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011. The company was incorporated in 2006 and is headquartered in Laguna Hills, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time